Mitsubishi UFJ Trust & Banking’s Janux Therapeutics JANX Stock Holding History

Mitsubishi UFJ Trust & Banking’s Portfolio JANX Stock Details JANX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$136K	Buy	+8,832	New	+$128K	﹤0.01%	1444

Other funds holding JANX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NNPTE

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne Warszawa, Poland $1.83B AUM 331.52% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking's JANX Position: Q2 2026 in Review

Mitsubishi UFJ Trust & Banking opened a new position in Janux Therapeutics (JANX) in Q2 2026: 8,832 shares worth $136K. The stake represents ﹤0.01% of the portfolio and ranks #1444 among its holdings.

61 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

Mitsubishi UFJ Trust & Banking held 8,832 shares of Janux Therapeutics worth $136K as of Q2 2026.
Janux Therapeutics was a new Mitsubishi UFJ Trust & Banking position in Q2 2026.
Janux Therapeutics made up ﹤0.01% of Mitsubishi UFJ Trust & Banking's portfolio in Q2 2026, its #1444 holding.
61 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2026, filed 6 Aug 2026.